Browse Drug Recalls

18,041 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 18,041 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 18,041 FDA drug recalls.

DateProductReasonClassFirm
Oct 10, 2019 Lyophilized Human Chorionic Gonadotropin 5,500 USP Units For injection, Rx On... Lack of Sterility Assurance. Class II Innoveix Pharmaceuticals Inc
Oct 10, 2019 Lyophilized Sermorelin w/ GHRP2 3 mg For injection, Rx Only, Compounded by: I... Lack of Sterility Assurance. Class II Innoveix Pharmaceuticals Inc
Oct 10, 2019 Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection, Rx Only, ... Lack of Sterility Assurance. Class II Innoveix Pharmaceuticals Inc
Oct 10, 2019 Lyophilized Human Chorionic Gonadotropin 5,000 USP Units For injection, Rx On... Lack of Sterility Assurance. Class II Innoveix Pharmaceuticals Inc
Oct 9, 2019 del Nido Cardioplegia Solution, 1000 mL, Single-Dose Container, Rx Only Nephr... Lack of Assurance of Sterility; bags have potential to leak Class II Nephron Pharmaceuticals Corporation dba Nephron...
Oct 9, 2019 PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride ... GMP Deviations: potential glass contamination Class II Nephron Pharmaceuticals Corporation dba Nephron...
Oct 9, 2019 Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose ... Crystallization: Presence of particulate matter identified as API crystallization Class II Ingenus Pharmaceuticals Llc
Oct 9, 2019 Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysi... Lack of Assurance of Sterility; bags have potential to leak Class II Nephron Pharmaceuticals Corporation dba Nephron...
Oct 9, 2019 PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chlorid... GMP Deviations: potential glass contamination Class II Nephron Pharmaceuticals Corporation dba Nephron...
Oct 9, 2019 PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chlo... GMP Deviations: potential glass contamination Class II Nephron Pharmaceuticals Corporation dba Nephron...
Oct 7, 2019 Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan I... Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity resu... Class II Mylan Laboratories Limited (Sterile Products Di...
Oct 4, 2019 Methylphenidate Hydrochloride Oral Solution 5mg per 5mL, 500 mL Bottle, Sugar... Presence of Foreign Substance; Fiber particles. Class III KVK-Tech, Inc.
Oct 2, 2019 10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 ... Lack of Assurance of Sterility: Bag has the potential to leak. Class II Pfizer Inc.
Oct 1, 2019 Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distri... Subpotent Drug Class III Sato Pharmaceutical Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 1... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) ... Subpotent Drug: Formulated amount of sennosides component is less than labelled claim. Class III Sato Pharmaceutical Inc.
Oct 1, 2019 Ranitidine Tablets 75 mg, a.) 30 count bottles (NDC 63868-482-30), 60 count b... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC. CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, D... Subpotent Drug Class III Sato Pharmaceutical Inc.
Oct 1, 2019 Ranitidine Tablets, USP 75 mg 30 count bottles (NDC 30142-131-30) (Kroger) CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 75 mg, NDC 57896-715 (GeriCare) OTC. CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) ... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (... Subpotent Drug Class III Sato Pharmaceutical Inc.
Oct 1, 2019 Ranitidine Tablets, USP 75 mg, a.) 30- count bottles (NDC 0363-0131-30), b.) ... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, NDC 57896-717 (GeriCare) OTC CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 30142-505-34), b.) ... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, 190 count bottles (2x95) Tray (Sam's Club) OT... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distribute... Subpotent Drug Class III Sato Pharmaceutical Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, a.) 95 count bottles (NDC 43598-808-62), b.) ... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-3... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 0363-0010-34), b.) ... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 71713-203-02), b.)9... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Ranitidine Tablets, USP 75 mg, a.) 30 count bottles (NDC 69842-871-30) b.) 80... CGMP Deviations: Presence of NDMA impurity detected in product. Class II Dr. Reddy's Laboratories, Inc.
Oct 1, 2019 Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injectio... Lack of sterility assurance. Class II New Vitalis Pharmacy LLC dba New Vitalis Pharmacy
Sep 27, 2019 Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Man... Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert... Class II Taro Pharmaceuticals U.S.A., Inc.
Sep 27, 2019 Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-... Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert... Class II Taro Pharmaceuticals U.S.A., Inc.
Sep 27, 2019 Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-... Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert... Class II Taro Pharmaceuticals U.S.A., Inc.
Sep 27, 2019 Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose,... Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1... Class III Arbor Pharmaceuticals Inc.
Sep 27, 2019 Ibuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL), Rx only, Manu... Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert... Class II Taro Pharmaceuticals U.S.A., Inc.
Sep 27, 2019 Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-... Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert... Class II Taro Pharmaceuticals U.S.A., Inc.
Sep 26, 2019 Estradiol tablets, 0.5 mg, 100-count bottles, Rx only, Distributed by Epic P... Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol... Class II Epic Pharma, LLC
Sep 26, 2019 Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial.... Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed ... Class II Alkermes, Inc.
Sep 24, 2019 Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Table... GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class II Apotex Inc.
Sep 24, 2019 Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by... Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle Class III Amneal Pharmaceuticals, Inc.
Sep 24, 2019 Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer Cool Mint... GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class II Apotex Inc.
Sep 24, 2019 Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg Cool Mint A... GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class II Apotex Inc.
Sep 24, 2019 Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg-acid reduce... GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class II Apotex Inc.

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.